The American Journal of Managed Care (4/22, McCrear) reports a study found that “although total Medicaid beneficiaries with opioid use disorder (OUD) have declined since 2019, the percentage of patients receiving medications for OUD (MOUD) has increased.” Study results showed that “the percentage of Medicaid beneficiaries diagnosed with OUD decreased from 4.2% (n = 738,060) in 2019 to 3.6% (n = 1,046,075) in 2023.” According to researchers, “in the 47 states plus the District of Columbia, the combined percentage of beneficiaries diagnosed with OUD and who received MOUD increased from 60.0% (n = 443,010 of 738,060) in 2019 to 69.1% (n = 723,177 of 1,046,075) in 2023.” The study was published in JAMA Network Open.
Related Links:
— “Medication Use Up for OUD as Diagnoses Decline Among Medicaid Beneficiaries,”Sabrina McCrear, , April 22, 2026